Condition

Alzheimer&#39;s Disease (AD)

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting2

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative DisordersNCT06803784 · 2025-02-04

RECRUITING

Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older AdultsNCT06715995 · 2024-12-09

RECRUITING

Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's DiseaseNCT06706947 · 2024-12-01

NOT_YET_RECRUITING

Common interventions

Gamma Wave Stimulation Table Lamp (Aleddra, Inc., USA)DEVICE1 Genetic: whole genome sequencingGENETIC1 Lymphaticovenous AnastomosisPROCEDURE1 whole exome sequencingGENETIC1

Leading sponsors

Chang Gung Memorial Hospital 1 Luo Xinxin 1 Neuromed IRCCS 1

Trial status mix

RECRUITING2

NOT_YET_RECRUITING1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.